AVTR:NYE-Avantor Inc (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 16.18

Change

0.00 (0.00)%

Market Cap

USD 11.92B

Volume

5.00M

Analyst Target

USD 23.81
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-30 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

N/A

USD 65.91B
ALC Alcon AG

N/A

USD 46.01B
RMD ResMed Inc

N/A

USD 34.14B
BAX Baxter International Inc

N/A

USD 18.71B
ATR AptarGroup Inc

N/A

USD 10.16B
TFX Teleflex Incorporated

N/A

USD 6.39B
STVN Stevanato Group SpA

N/A

USD 5.88B
BLCO Bausch + Lomb Corp

N/A

USD 5.64B
WRBY Warby Parker Inc

N/A

USD 2.55B
INFU InfuSystems Holdings Inc

N/A

USD 0.13B

ETFs Containing AVTR

COPP Sprott Copper Miners ETF 10.10 % 0.00 %

N/A

N/A
CEBS:XETRA iShares Copper Miners UCI.. 5.61 % 0.00 %

N/A

USD 0.05B
WIRE:AU Global X Copper Miners ET.. 5.25 % 0.00 %

N/A

N/A
COPG:LSE Global X Copper Miners UC.. 5.14 % 0.00 %

N/A

USD 0.15B
4COP:XETRA Global X Copper Miners UC.. 5.13 % 0.00 %

N/A

USD 0.09B
XMET:AU BetaShares Energy Transit.. 4.85 % 0.00 %

N/A

N/A
COPA Themes Copper Miners ETF 4.57 % 0.00 %

N/A

USD 0.50M
COPX:SW Global X Copper Miners UC.. 4.56 % 0.00 %

N/A

N/A
D6AT:XETRA Global X Disruptive Mater.. 4.46 % 0.00 %

N/A

N/A
GMTL:AU Global X Green Metal Mine.. 4.40 % 0.00 %

N/A

N/A
COPX:LSE Global X Copper Miners UC.. 4.31 % 0.00 %

N/A

N/A
DMAT Global X Disruptive Mater.. 3.67 % 0.00 %

N/A

USD 4.90M
SETM:LSE 3.14 % 0.00 %

N/A

N/A
CRIT Optica Rare Earths & Crit.. 2.63 % 0.00 %

N/A

USD 3.25M
BSJO 0.00 % 0.42 %

N/A

N/A
COPX Global X Copper Miners ET.. 0.00 % 0.65 %

N/A

USD 2.69B
IVOV Vanguard S&P Mid-Cap 400 .. 0.00 % 0.20 %

N/A

USD 0.87B
HYDW Xtrackers Low Beta High Y.. 0.00 % 0.25 %

N/A

USD 0.19B
PQIN 0.00 % 0.00 %

N/A

N/A
IESZ:LSE 0.00 % 0.00 %

N/A

N/A
EXV6:F 0.00 % 0.00 %

N/A

N/A
EXV6:XETRA iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

USD 0.37B
BRHY BlackRock High Yield ETF 0.00 % 0.00 %

N/A

USD 0.10B

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -23.21% 17% F 7% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -23.21% 17% F 7% C-
Trailing 12 Months  
Capital Gain -36.72% 28% F 8% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return -36.72% 22% F 7% C-
Trailing 5 Years  
Capital Gain 29.54% 67% D+ 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.54% 67% D+ 30% F
Average Annual (5 Year Horizon)  
Capital Gain 7.86% 76% C+ 61% D-
Dividend Return 7.86% 76% C+ 54% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 43.08% 33% F 21% F
Risk Adjusted Return 18.24% 67% D+ 34% F
Market Capitalization 11.92B 71% C- 88% B+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector